Author

M. Galhaut

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:non-human primate· 3 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

R. Le Grand· 3 shared F. Relouzat· 2 shared R. Marlin· 2 shared A. Nougairede· 1 shared A. Rousseau· 1 shared A. Wiedemann· 1 shared A.-S. Gallouët· 1 shared B. Delache· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

R. Le Grand

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multimodal mucosal and systemic immune characterization of a novel non-human primate trachoma model highlights the critical role of local immunity during acute phase disease

E. Paulet, V. Contreras, M. Galhaut, I. Rosenkrands, M. Holland, M. Burton, J. Dietrich, A.-S. Gallouët, N. Bosquet, F. Relouzat, S. Langlois, F. Follmann, R. Le Grand, M. Labetoulle, A. Rousseau

This study develops a non-human primate model of acute trachoma and characterizes the local immune response kinetics following Chlamydia trachomatis infection.

bioRxiv · Dec 5, 2023Microbiology

Sotrovimab retains activity against SARS-CoV-2 Omicron variant BQ.1.1 in a non-human primate model

C. Herate, R. Marlin, F. Touret, N. D. Bosquet, F. Donati, F. Relouzat, L. Junges, M. Galhaut, O. Dehan, Q. Sconosciutti, A. Nougairede, X. de Lamballerie, S. van der Werf, R. Le Grand

This study shows Sotrovimab remains effective against SARS-CoV-2 BQ.1.1 in a non-human primate model, as measured by reduced viral replication.

bioRxiv · Feb 15, 2023Pathology

SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines

M. Alexandre, R. Marlin, M. Prague, C. Severin, N. Kahlaoui, S. Cardinaud, T. Naninck, B. Delache, M. Surenaud, M. Galhaut, N. Dereuddre-Bosquet, M. Cavarelli, P. Maisonnasse, M. Centlivre, C. Lacabaratz, , R. Thiebaut

A mathematical model of viral dynamics is used to identify mechanistic correlates of protection in SARS-CoV-2 vaccines across three non-human primate studies.

bioRxiv · Oct 29, 2021Immunology